Pulsed Electromagnetic Fields for Clinical Applications
暫譯: 臨床應用的脈衝電磁場

《脈衝電磁場在臨床應用中的應用》介紹了脈衝電磁場（PEMFs）的歷史發展、現狀及未來，並探討其在治療各種醫療問題中的應用，包括促進延遲骨折的癒合過程、緩解疼痛、以及治療多發性硬化症和帕金森病。重點在於開發可在臨床應用中實施的科學方法。

從整體來看，這種模式提供了一種實用的外源性方法，用於促進細胞和組織的改變，旨在將受傷組織恢復到其正常生理狀態。該書回顧了PEMF設備的現狀，並突顯了全球的治療成就。

- 探討了PEMF療法的過去、現在和未來。
- 介紹了過去70年來理論和實驗室研究的發展。
- 回顧了可用的PEMF設備。
- 評估了全球治療成就的最新進展。
- 包含了電穿孔模式的最新成就和應用。

Marko S. Markov received his BS, MS and PhD from Sofia University, Bulgaria. He has been Professor and Chairman of the Department of Biophysics and Radiobiology at Sofia University for 22 years. He had been invited professor and lecturer in a number of European, Japanese and American academic and industry entities. For the years his research was on biological and clinical studies of the effects of various electromagnetic fields. He is a founder and member of the Editorial board of the journal Electromagnetic biology and medicine. He has ben author and co-author of more that 200 peer-reviewed papers. Dr. Markov is author, editor and co-editor of 26 books, published by Plenum Press, Springer, Marcel Dekker and CRC. His book Electromagnetic fields in biology and medicine published by CRC Press is being translated on mandarin in China.

Jim Ryaby, PhD joined Orthofix as Chief Scientific Officer in July 2013 after serving as a consultant. Before joining the Company, he served as Vice President of Research and Clinical Affairs for musculoskeletal applications at Mesoblast. Dr. Ryaby has also held the position of Senior Vice President of Research and Clinical Affairs and Chief Scientific Officer at OrthoLogic Corp in Tempe, AZ. where he led the development of the CMF technology for spine fusion and nonunions and the TP508 peptide therapeutic development program in orthopedic and diabetic ulcer applications. Additionally, he has served as Adjunct Professor of Bioengineering at Arizona State University. Dr. Ryaby received his PhD degree in cellular and molecular biology from the Mt. Sinai School of Medicine, New York.

Erik I. Waldorff, PhD, is the Principal Scientist and Research Manager for the orthopedic medical device company, Orthofix, which he joined in 2012. Prior to this Dr. Waldorff served as a Clinical Research Scientist for the Neuromodulation Division at St. Jude Medical (now Abbott) where he performed pre-clinical studies in addition to post-market clinical trials for spinal cord stimulation and deep brain stimulation patients. In addition following his doctoral studies, Dr. Waldorff held a position as a Postdoctoral Fellow at the Michigan Institute for Clinical and Health Research (MICHR) at the University of Michigan where he led orthopaedic human and animal studies. Dr. Waldorff received his PhD and MSE degrees in Biomedical Engineering and MSE and BSE degrees in Aerospace Engineering from the University of Michigan (Ann Arbor, Michigan).

馬爾科·S·馬爾科夫（Marko S. Markov）於保加利亞索非亞大學獲得學士、碩士及博士學位。他在索非亞大學生物物理與放射生物學系擔任教授及系主任已有22年。他曾受邀於多個歐洲、日本及美國的學術和產業機構擔任教授及講師。多年來，他的研究專注於各種電磁場的生物及臨床影響研究。他是《電磁生物學與醫學》期刊的創始人及編輯委員會成員。他是200多篇經過同行評審的論文的作者及合著者。馬爾科夫博士是26本書籍的作者、編輯及共同編輯，這些書籍由Plenum Press、Springer、Marcel Dekker及CRC出版。他的書籍《生物學與醫學中的電磁場》由CRC Press出版，正在中國翻譯成中文。

吉姆·瑞比（Jim Ryaby）博士於2013年7月加入Orthofix擔任首席科學官，此前曾擔任顧問。在加入該公司之前，他曾擔任Mesoblast的肌肉骨骼應用研究及臨床事務副總裁。瑞比博士還曾擔任位於亞利桑那州坦佩的OrthoLogic Corp的研究及臨床事務高級副總裁及首席科學官，負責脊椎融合及不癒合的CMF技術開發，以及TP508肽的治療開發計劃，應用於骨科及糖尿病潰瘍。此外，他還擔任亞利桑那州立大學的生物工程兼任教授。瑞比博士在紐約的西奈山醫學院獲得細胞與分子生物學博士學位。

埃里克·I·瓦爾多夫（Erik I. Waldorff）博士是骨科醫療器械公司Orthofix的首席科學家及研究經理，自2012年加入該公司。此前，瓦爾多夫博士曾擔任聖猶達醫療（現為Abbott）神經調節部門的臨床研究科學家，負責脊髓刺激及深腦刺激患者的臨床前研究及市場後臨床試驗。此外，在完成博士學位後，瓦爾多夫博士在密西根大學的臨床與健康研究所（MICHR）擔任博士後研究員，負責骨科的人類及動物研究。瓦爾多夫博士在密西根大學（安娜堡，密西根州）獲得生物醫學工程的博士及碩士學位，以及航空航天工程的碩士及學士學位。